Essilorluxottica (OTC) ( (ESLOY) ) has released its Q2 earnings. Here is a breakdown of the information Essilorluxottica (OTC) presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EssilorLuxottica is a global leader in the design, manufacture, and distribution of advanced vision care products and eyewear, operating in the med-tech sector with a focus on innovation and sustainability. The company reported a 7.3% revenue growth in both Q2 and H1 2025, driven by strong performances across all regions and segments. Key highlights include a significant increase in sales of AI glasses, stable operating margins, and robust free cash flow generation. The acquisition of Optegra clinics marks a strategic step into the med-tech journey, enhancing the company’s comprehensive eyecare offerings. Looking forward, EssilorLuxottica remains committed to its growth targets and innovation in the eyewear and med-tech industry, aiming for mid-single-digit annual revenue growth and an adjusted operating profit margin of 19-20% by 2026.